Neu-REFIX Beta glucan receives rare pediatric disease and orphan drug designations from the US FDA for treatment of Duchenne Muscular Dystrophy

TOKYO, Japan:   Neu REFIX Beta glucan, made in Japan has received both Rare Pediatric Disease Designation (RPDD) and Orphan Drug

READ MORE

Environmental Factor – March 2023: Toxic protein linked to muscular dystrophy, rare facial malformation

NIEHS researchers and their colleagues have found that a toxic protein made by the body called DUX4 may be the cause of two very different

READ MORE